Intuitive Surgical (NASDAQ:ISRG) Shares Up 0.9%

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) shares rose 0.9% on Tuesday . The company traded as high as $387.00 and last traded at $386.66. Approximately 143,698 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 1,599,038 shares. The stock had previously closed at $383.05.

Wall Street Analyst Weigh In

ISRG has been the topic of several recent research reports. Stifel Nicolaus upped their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a "buy" rating in a research note on Monday, April 8th. Robert W. Baird reduced their price target on Intuitive Surgical from $440.00 to $436.00 and set an "outperform" rating for the company in a report on Friday, April 19th. BTIG Research upped their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a "buy" rating in a research note on Friday, April 19th. Piper Sandler raised their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an "overweight" rating in a research note on Friday, April 19th. Finally, Raymond James lifted their target price on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an "outperform" rating in a report on Thursday, January 25th. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $396.17.

Intuitive Surgical Trading Up 1.5 %

The stock has a 50 day simple moving average of $385.34 and a 200-day simple moving average of $351.97. The firm has a market capitalization of $137.86 billion, a P/E ratio of 70.15, a P/E/G ratio of 4.93 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the previous year, the company posted $1.00 earnings per share. Intuitive Surgical's revenue for the quarter was up 11.5% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Mark J. Rubash sold 1,709 shares of the stock in a transaction dated Friday, May 3rd. The stock was sold at an average price of $380.00, for a total transaction of $649,420.00. Following the completion of the sale, the director now owns 16,051 shares in the company, valued at $6,099,380. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares of the company's stock, valued at approximately $736,800. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mark J. Rubash sold 1,709 shares of the firm's stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $380.00, for a total value of $649,420.00. Following the transaction, the director now owns 16,051 shares of the company's stock, valued at approximately $6,099,380. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 228,637 shares of company stock worth $88,483,248. Company insiders own 0.80% of the company's stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Provence Wealth Management Group bought a new position in shares of Intuitive Surgical in the 4th quarter valued at about $276,000. Portside Wealth Group LLC boosted its holdings in shares of Intuitive Surgical by 8.2% in the 4th quarter. Portside Wealth Group LLC now owns 816 shares of the medical equipment provider's stock worth $275,000 after purchasing an additional 62 shares during the period. Sequoia Financial Advisors LLC increased its position in shares of Intuitive Surgical by 58.0% during the 4th quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider's stock valued at $2,805,000 after purchasing an additional 3,054 shares during the last quarter. Kades & Cheifetz LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $230,000. Finally, Blair William & Co. IL lifted its position in Intuitive Surgical by 3.1% in the third quarter. Blair William & Co. IL now owns 377,371 shares of the medical equipment provider's stock worth $110,302,000 after buying an additional 11,400 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.